Pancreatic Cancer Precision Medicine Market (2025 - 2030) Size, Share & Trends Analysis Report By Therapeutic Approach (Targeted Therapy, Immunotherapy, Chemotherapy-precision Combinations), By Diagnostic Technology, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Therapeutic Approach
                        1.2.2. Diagnostic Technology
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Pancreatic Cancer Precision Medicine Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Business Environment Analysis
                        3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                            3.3.1.1. Supplier Power
                            3.3.1.2. Buyer Power
                            3.3.1.3. Substitution Threat
                            3.3.1.4. Threat of New Entrants
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTLE Analysis
Chapter 4. Pancreatic Cancer Precision Medicine Market: Therapeutic Approach Business Analysis
                    4.1. Therapeutic Approach Market Share, 2024 & 2030
                    4.2. Therapeutic Approach Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Therapeutic Approach, 2018 to 2030 (USD Million)
                    4.4. Targeted Therapy
                        4.4.1. Targeted Therapy Market, 2018 - 2030 (USD Million)
                    4.5. PARP Inhibitors
                        4.5.1. PARP Inhibitors Market, 2018 - 2030 (USD Million)
                    4.6. Monoclonal Antibodies
                        4.6.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Million)
                    4.7. Small Molecule Inhibitors - EGFR Inhibitors, KRAS Inhibitors
                        4.7.1. Small Molecule Inhibitors - EGFR Inhibitors, KRAS Inhibitors Market, 2018 - 2030 (USD Million)
                    4.8. Immunotherapy
                        4.8.1. Immunotherapy Market, 2018 - 2030 (USD Million)
                    4.9. Immune Checkpoint Inhibitors - PD-1 Inhibitors, PD-L1 Inhibitors
                        4.9.1. Immune Checkpoint Inhibitors - PD-1 Inhibitors, PD-L1 Inhibitors Market, 2018 - 2030 (USD Million)
                    4.10. Cancer Vaccines - GVAX, Algenpantucel-L
                        4.10.1. Cancer Vaccines - GVAX, Algenpantucel-L Market, 2018 - 2030 (USD Million)
                    4.11. Adoptive T-Cell Therapies - CAR-T Therapies
                        4.11.1. Adoptive T-Cell Therapies - CAR-T Therapies Market, 2018 - 2030 (USD Million)
                    4.12. Chemotherapy-Precision Combinations
                        4.12.1. Chemotherapy-Precision Combinations Market, 2018 - 2030 (USD Million)
                    4.13. Other Therapeutic Approaches
                        4.13.1. Other Therapeutic Approaches Market, 2018 - 2030 (USD Million)
Chapter 5. Pancreatic Cancer Precision Medicine Market: Diagnostic Technology Business Analysis
                    5.1. Diagnostic Technology Market Share, 2024 & 2030
                    5.2. Diagnostic Technology Segment Dashboard
                    5.3. Market Size & Forecasts and Trend Analysis, by Diagnostic Technology, 2018 to 2030 (USD Million)
                    5.4. Genomic Testing
                        5.4.1. Genomic Testing Market, 2018 - 2030 (USD Million)
                    5.5. Molecular Diagnostics
                        5.5.1. Molecular Diagnostics Market, 2018 - 2030 (USD Million)
                    5.6. Liquid Biopsy
                        5.6.1. Liquid Biopsy Market, 2018 - 2030 (USD Million)
                    5.7. Biomarker-based Companion Diagnostics
                        5.7.1. Biomarker-based Companion Diagnostics Market, 2018 - 2030 (USD Million)
                    5.8. Others (Immunohistochemistry (IHC), Proteomics, Mass Spectrometry)
                        5.8.1. Others (Immunohistochemistry (IHC), Proteomics, Mass Spectrometry) Market, 2018 - 2030 (USD Million)
Chapter 6. Pancreatic Cancer Precision Medicine Market: Regional Estimates & Trend Analysis
                    6.1. Regional Market Share Analysis, 2024 & 2030
                    6.2. Regional Market Dashboard
                    6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
                    6.4. North America
                        6.4.1. North America Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
                        6.4.2. U.S.
                            6.4.2.1. Key Country Dynamics
                            6.4.2.2. Regulatory Framework
                            6.4.2.3. Competitive Insights
                            6.4.2.4. U.S. Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.4.3. Canada
                            6.4.3.1. Key Country Dynamics
                            6.4.3.2. Regulatory Framework
                            6.4.3.3. Competitive Insights
                            6.4.3.4. Canada Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.4.4. Mexico
                            6.4.4.1. Key Country Dynamics
                            6.4.4.2. Regulatory Framework
                            6.4.4.3. Competitive Insights
                            6.4.4.4. Mexico Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                    6.5. Europe
                        6.5.1. Europe Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
                        6.5.2. UK
                            6.5.2.1. Key Country Dynamics
                            6.5.2.2. Regulatory Framework
                            6.5.2.3. Competitive Insights
                            6.5.2.4. UK Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.5.3. Germany
                            6.5.3.1. Key Country Dynamics
                            6.5.3.2. Regulatory Framework
                            6.5.3.3. Competitive Insights
                            6.5.3.4. Germany Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.5.4. France
                            6.5.4.1. Key Country Dynamics
                            6.5.4.2. Regulatory Framework
                            6.5.4.3. Competitive Insights
                            6.5.4.4. France Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.5.5. Italy
                            6.5.5.1. Key Country Dynamics
                            6.5.5.2. Regulatory Framework
                            6.5.5.3. Competitive Insights
                            6.5.5.4. Italy Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.5.6. Spain
                            6.5.6.1. Key Country Dynamics
                            6.5.6.2. Regulatory Framework
                            6.5.6.3. Competitive Insights
                            6.5.6.4. Spain Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.5.7. Norway
                            6.5.7.1. Key Country Dynamics
                            6.5.7.2. Regulatory Framework
                            6.5.7.3. Competitive Insights
                            6.5.7.4. Norway Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.5.8. Denmark
                            6.5.8.1. Key Country Dynamics
                            6.5.8.2. Regulatory Framework
                            6.5.8.3. Competitive Insights
                            6.5.8.4. Denmark Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.5.9. Sweden
                            6.5.9.1. Key Country Dynamics
                            6.5.9.2. Regulatory Framework
                            6.5.9.3. Competitive Insights
                            6.5.9.4. Sweden Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                    6.6. Asia Pacific
                        6.6.1. Asia Pacific Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
                        6.6.2. Japan
                            6.6.2.1. Key Country Dynamics
                            6.6.2.2. Regulatory Framework
                            6.6.2.3. Competitive Insights
                            6.6.2.4. Japan Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.6.3. China
                            6.6.3.1. Key Country Dynamics
                            6.6.3.2. Regulatory Framework
                            6.6.3.3. Competitive Insights
                            6.6.3.4. China Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.6.4. India
                            6.6.4.1. Key Country Dynamics
                            6.6.4.2. Regulatory Framework
                            6.6.4.3. Competitive Insights
                            6.6.4.4. India Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.6.5. South Korea
                            6.6.5.1. Key Country Dynamics
                            6.6.5.2. Regulatory Framework
                            6.6.5.3. Competitive Insights
                            6.6.5.4. South Korea Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.6.6. Australia
                            6.6.6.1. Key Country Dynamics
                            6.6.6.2. Regulatory Framework
                            6.6.6.3. Competitive Insights
                            6.6.6.4. Australia Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.6.7. Thailand
                            6.6.7.1. Key Country Dynamics
                            6.6.7.2. Regulatory Framework
                            6.6.7.3. Competitive Insights
                            6.6.7.4. Thailand Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                    6.7. Latin America
                        6.7.1. Latin America Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
                        6.7.2. Brazil
                            6.7.2.1. Key Country Dynamics
                            6.7.2.2. Regulatory Framework
                            6.7.2.3. Competitive Insights
                            6.7.2.4. Brazil Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.7.3. Argentina
                            6.7.3.1. Key Country Dynamics
                            6.7.3.2. Regulatory Framework
                            6.7.3.3. Competitive Insights
                            6.7.3.4. Argentina Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                    6.8. MEA
                        6.8.1. MEA Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
                        6.8.2. South Africa
                            6.8.2.1. Key Country Dynamics
                            6.8.2.2. Regulatory Framework
                            6.8.2.3. Competitive Insights
                            6.8.2.4. South Africa Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.8.3. Saudi Arabia
                            6.8.3.1. Key Country Dynamics
                            6.8.3.2. Regulatory Framework
                            6.8.3.3. Competitive Insights
                            6.8.3.4. Saudi Arabia Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.8.4. UAE
                            6.8.4.1. Key Country Dynamics
                            6.8.4.2. Regulatory Framework
                            6.8.4.3. Competitive Insights
                            6.8.4.4. UAE Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
                        6.8.5. Kuwait
                            6.8.5.1. Key Country Dynamics
                            6.8.5.2. Regulatory Framework
                            6.8.5.3. Competitive Insights
                            6.8.5.4. Kuwait Pancreatic Cancer Precision Medicine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Participant Overview
                    7.2. Company Market Position Analysis
                    7.3. Company Categorization
                    7.4. Strategy Mapping
                    7.5. Company Profiles/Listing
                        7.5.1. AstraZeneca
                            7.5.1.1. Overview
                            7.5.1.2. Financial Performance
                            7.5.1.3. Product Benchmarking
                            7.5.1.4. Strategic Initiatives
                        7.5.2. Pfizer Inc.
                            7.5.2.1. Overview
                            7.5.2.2. Financial Performance
                            7.5.2.3. Product Benchmarking
                            7.5.2.4. Strategic Initiatives
                        7.5.3. Novartis AG
                            7.5.3.1. Overview
                            7.5.3.2. Financial Performance
                            7.5.3.3. Product Benchmarking
                            7.5.3.4. Strategic Initiatives
                        7.5.4. Amgen Inc.
                            7.5.4.1. Overview
                            7.5.4.2. Financial Performance
                            7.5.4.3. Product Benchmarking
                            7.5.4.4. Strategic Initiatives
                        7.5.5. F. Hoffmann-La Roche Ltd
                            7.5.5.1. Overview
                            7.5.5.2. Financial Performance
                            7.5.5.3. Product Benchmarking
                            7.5.5.4. Strategic Initiatives
                        7.5.6. Bayer AG
                            7.5.6.1. Overview
                            7.5.6.2. Financial Performance
                            7.5.6.3. Product Benchmarking
                            7.5.6.4. Strategic Initiatives
                        7.5.7. Eli Lilly and Company
                            7.5.7.1. Overview
                            7.5.7.2. Financial Performance
                            7.5.7.3. Product Benchmarking
                            7.5.7.4. Strategic Initiatives
                        7.5.8. Merck & Co., Inc.
                            7.5.8.1. Overview
                            7.5.8.2. Financial Performance
                            7.5.8.3. Product Benchmarking
                            7.5.8.4. Strategic Initiatives
                        7.5.9. Teva Pharmaceutical Industries Ltd
                            7.5.9.1. Overview
                            7.5.9.2. Financial Performance
                            7.5.9.3. Product Benchmarking
                            7.5.9.4. Strategic Initiatives
                        7.5.10. PharmaCyte Biotech, Inc.
                            7.5.10.1. Overview
                            7.5.10.2. Financial Performance
                            7.5.10.3. Product Benchmarking
                            7.5.10.4. Strategic Initiatives
                        7.5.11. Genentech, Inc.
                            7.5.11.1. Overview
                            7.5.11.2. Financial Performance
                            7.5.11.3. Product Benchmarking
                            7.5.11.4. Strategic Initiatives
                        7.5.12. Guardant Health
                            7.5.12.1. Overview
                            7.5.12.2. Financial Performance
                            7.5.12.3. Product Benchmarking
                            7.5.12.4. Strategic Initiatives
                        7.5.13. Illumina, Inc.
                            7.5.13.1. Overview
                            7.5.13.2. Financial Performance
                            7.5.13.3. Product Benchmarking
                            7.5.13.4. Strategic Initiatives
                        7.5.14. Thermo Fisher Scientific Inc.
                            7.5.14.1. Overview
                            7.5.14.2. Financial Performance
                            7.5.14.3. Product Benchmarking
                            7.5.14.4. Strategic Initiatives
                        7.5.15. FOUNDATION MEDICINE, INC.
                            7.5.15.1. Overview
                            7.5.15.2. Financial Performance
                            7.5.15.3. Product Benchmarking
                            7.5.15.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global pancreatic cancer precision medicine market, by region, 2018 - 2030 (USD Million)
Table 4 Global pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 5 Global pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 6 North America pancreatic cancer precision medicine market, by country, 2018 - 2030 (USD Million)
Table 7 North America pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 8 North America pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 9 U.S. pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 10 U.S. Pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 11 Canada pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 12 Canada pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 13 Mexico pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 14 Mexico pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 15 Europe pancreatic cancer precision medicine market, by country, 2018 - 2030 (USD Million)
Table 16 Europe pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 17 Europe pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 18 UK pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 19 UK Pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 20 Germany pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 21 Germany pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 22 France pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 23 France Pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 24 Italy pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 25 Italy pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 26 Spain pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 27 Spain pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 28 Norway pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 29 Norway Pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 30 Denmark pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 31 Denmark pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 32 Sweden pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 33 Sweden pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 34 Asia Pacific pancreatic cancer precision medicine market, by country, 2018 - 2030 (USD Million)
Table 35 Asia Pacific pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 36 Asia Pacific pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 37 Japan pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 38 Japan pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 39 China pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 40 China pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 41 India pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 42 India pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 43 Australia pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 44 Australia pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 45 South Korea pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 46 South Korea pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 47 Thailand pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 48 Thailand pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 49 Latin America pancreatic cancer precision medicine market, by country, 2018 - 2030 (USD Million)
Table 50 Latin America pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 51 Latin America pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 52 Brazil pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 53 Brazil pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 54 Argentina pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 55 Argentina pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa Pancreatic cancer precision medicine market, by country, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 58 Middle East & Africa pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 59 South Africa pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 60 South Africa pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 63 UAE pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 64 UAE pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)
Table 65 Kuwait pancreatic cancer precision medicine market, by therapeutic approach, 2018 - 2030 (USD Million)
Table 66 Kuwait pancreatic cancer precision medicine market, by diagnostic technology, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Pancreatic cancer precision medicine market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach and diagnostic technology outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Pancreatic cancer precision medicine market dynamics
Fig. 12 Pancreatic cancer precision medicine market: Porter’s five forces analysis
Fig. 13 Pancreatic cancer precision medicine market: PESTLE analysis
Fig. 14 Pancreatic cancer precision medicine market: Therapeutic approach segment dashboard
Fig. 15 Pancreatic cancer precision medicine market: Therapeutic approach market share analysis, 2024 & 2030
Fig. 16 Targeted therapy market, 2018 - 2030 (USD Million)
Fig. 17 PARP inhibitors market, 2018 - 2030 (USD Million)
Fig. 18 Monoclonal antibodies market, 2018 - 2030 (USD Million)
Fig. 19 Small molecule inhibitors - EGFR inhibitors, KRAS inhibitors market, 2018 - 2030 (USD Million)
Fig. 20 Immunotherapy market, 2018 - 2030 (USD Million)
Fig. 21 Immune checkpoint inhibitors - PD-1 inhibitors, PD-L1 inhibitors market, 2018 - 2030 (USD Million)
Fig. 22 Cancer vaccines - GVAX, Algenpantucel-L market, 2018 - 2030 (USD Million)
Fig. 23 Adoptive T-Cell therapies - CAR-T therapies market, 2018 - 2030 (USD Million)
Fig. 24 Chemotherapy-precision combinations market, 2018 - 2030 (USD Million)
Fig. 25 Other therapeutic approaches market, 2018 - 2030 (USD Million)
Fig. 26 Pancreatic cancer precision medicine market: Diagnostic technology segment dashboard
Fig. 27 Pancreatic cancer precision medicine market: Diagnostic technology market share analysis, 2024 & 2030
Fig. 28 Genomic testing market, 2018 - 2030 (USD Million)
Fig. 29 Molecular diagnostics market, 2018 - 2030 (USD Million)
Fig. 30 Liquid biopsy market, 2018 - 2030 (USD Million)
Fig. 31 Biomarker-based companion diagnostics market, 2018 - 2030 (USD Million)
Fig. 32 Others (Immunohistochemistry (IHC), proteomics, mass spectrometry) market, 2018 - 2030 (USD Million)
Fig. 33 Pancreatic cancer precision medicine market revenue, by region
Fig. 34 Regional marketplace: Key takeaways
Fig. 35 Regional marketplace: Key takeaways
Fig. 36 North America pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 37 U.S. country dynamics
Fig. 38 U.S. pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 39 Canada country dynamics
Fig. 40 Canada pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 41 Mexico country dynamics
Fig. 42 Mexico pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 43 Europe pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 44 UK country dynamics
Fig. 45 UK pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 46 Germany country dynamics
Fig. 47 Germany pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 48 France country dynamics
Fig. 49 France pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 50 Italy country dynamics
Fig. 51 Italy pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 52 Spain country dynamics
Fig. 53 Spain pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 54 Norway country dynamics
Fig. 55 Norway pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 56 Sweden country dynamics
Fig. 57 Sweden pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 58 Denmark country dynamics
Fig. 59 Denmark pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 60 Asia Pacific pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 61 Japan country dynamics
Fig. 62 Japan pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 63 China country dynamics
Fig. 64 China pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 65 India country dynamics
Fig. 66 India pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 67 Australia country dynamics
Fig. 68 Australia pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 69 South Korea country dynamics
Fig. 70 South Korea pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 71 Thailand country dynamics
Fig. 72 Thailand pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 73 Latin America pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 74 Brazil country dynamics
Fig. 75 Brazil pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 76 Argentina country dynamics
Fig. 77 Argentina pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 78 MEA pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 79 South Africa country dynamics
Fig. 80 South Africa pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 81 Saudi Arabia country dynamics
Fig. 82 Saudi Arabia pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 83 UAE country dynamics
Fig. 84 UAE pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 85 Kuwait country dynamics
Fig. 86 Kuwait pancreatic cancer precision medicine market, 2018 - 2030 (USD Million)
Fig. 87 Company categorization
Fig. 88 Company market position analysis
Fig. 89 Strategic framework